Target profiling of zerumbone using a novel cell-permeable clickable probe and quantitative chemical proteomics.

Chem Commun (Camb)

Department of Chemistry, Imperial College London, South Kensington Campus, Exhibition Road, London SW7 2AZ, UK.

Published: March 2015


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Zerumbone is a phytochemical with diverse biological activities ranging from anti-inflammatory to anti-cancer properties; however, to date the cellular targets of this important compound have remained elusive. Here we report the global protein target spectrum of zerumbone in living cancer cells using competitive activity-based protein profiling of a novel cell-permeable clickable probe, combined with quantitative mass spectrometry.

Download full-text PDF

Source
http://dx.doi.org/10.1039/c4cc09527hDOI Listing

Publication Analysis

Top Keywords

novel cell-permeable
8
cell-permeable clickable
8
clickable probe
8
target profiling
4
profiling zerumbone
4
zerumbone novel
4
probe quantitative
4
quantitative chemical
4
chemical proteomics
4
proteomics zerumbone
4

Similar Publications

The N-methyl-d-aspartate receptor (NMDAR)-neuronal nitric oxide synthase (nNOS)-postsynaptic density-95 (PSD-95) ternary complex represents a promising therapeutic target for acute ischemic stroke treatment. Although the shortest peptide ETAV targeting the PDZ2 domain of PSD-95 shows therapeutic potential, its limit in vivo stability restricts its broad application. Therefore, we herein systematically optimized and developed a series of novel peptidomimetics based on ETAV.

View Article and Find Full Text PDF

Introduction: Toll-like receptors (TLRs) are critical components of innate immunity, recognizing microbe-derived molecules and triggering pro-inflammatory cytokine production for pathogen clearance. However, TLR hyperactivation can cause excessive inflammation, contributing to disorders such as sepsis. Thus, modulating TLR signalling is a promising therapeutic strategy.

View Article and Find Full Text PDF

Mutations in the adenomatous polyposis coli (APC) gene are common in colorectal cancer (CRC) and result in deregulation of β-catenin, a key driver of tumor initiation and progression. Despite its central role, targeted degradation of β-catenin remains an unmet therapeutic need in APC-mutant CRC. This study introduces and evaluates C-Arg9-APCR3-VHL, a novel PROTAC designed to promote β-catenin degradation via the VHL-Mediated ubiquitin-proteasome pathway.

View Article and Find Full Text PDF

Cerebral glucose hypometabolism is a cardinal molecular signature of Alzheimer's disease, and its role in the pathogenesis of this disorder is under intensive study in both animal and cell-based models. In the current study, we exposed SH-SY5Y cells (human neuroblastoma cell line) over a period of 48 h to DRB18, an inhibitor of multiple glucose transporters, in different concentrations to develop a state of glucose hypometabolism. Under this metabolic insult, in SH-SY5Y cells a profound dose-dependent neural cell death, an increased production of reactive oxygen radicals, mitochondrial membrane depolarization and a depletion of cellular ATP content were noted; these effects were not prevented by lipid-soluble novel antioxidants such as ferrostatin-1 and liproxstatin-1 or by a general water-soluble antioxidant like N-acetylcysteine.

View Article and Find Full Text PDF

Vitrification is a promising approach for cryopreserving complex biological structures such as organs. However, to prevent ice formation, high concentrations of cell-permeable cryoprotective agents (CPAs) are required, which can be highly toxic. The current reliance on a small number of CPAs limits optimization of low-toxicity compositions for vitrification.

View Article and Find Full Text PDF